Fabry Disease Market Evolution: Chaperone Therapy and...

2026-01-28 06:22:55 -

Fabry Disease Market Evolution: Chaperone Therapy and First-Generation Gene Therapies Target Unmet Needs in Lysosomal Storage Disorders

Enzyme Replacement Therapy Trials Showing Renal Stabilization 2026 Advancements in Intravenous Infusion Protocols Enzyme Replacement Therapy (ERT) remains a cornerstone in the management of individuals with this complex lysosomal storage disorder, caused by a deficiency in the alpha-galactosidase A enzyme. The therapy works by intravenously infusing a functional version of the deficient...

0 ความคิดเห็น 0 แชร์ 940 ยอดวิว 0 รีวิว